Spa Pharma Regenerating Pomegranate Cream

Drug Labeling and Warnings

Drug Details [pdf]

SPA PHARMA REGENERATING POMEGRANATE CREAM- octinoxate, octocrylene, avobenzone, homosalate cream cream 
Peer Pharma Ltd.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Spa Pharma Regenerating Pomegranate Cream

Spa Pharma Regenerating Pomegranate Cream SPF 25

Octinoxate 7.5%

Octocrylene 5%

Octisalate 5%

Avobenzone 3%

Homosalate 2%

Keep out of reach of children.

Provides SPF 25 protection

For external use only.
Do not use on damaged or broken skin.
When using this product, keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs.

Smooth on to face.

Water, Cetearyl Alcohol & Cetearyl Glucoside, Cyclopentasiloxane, Isohexadecane, Stearate & Peg-100 stearate, Glycerin, Simmondsia Chimensis (Jojoba) seed oil, Butyrospermum Parkii (shea) Butter, Potassim Cetyl Phosphate, Niacinamide (Vit.B3), Dehydroacetic Acid & Benzoic Acid & Phenoxyethanol, Dimethicone, Maris Sal (from dead sea), * Fragrance (supplement) , Allantoin, Aloe Barbadensis (Aloe Vera) Leaf extract, Retinyl Palmitate, Persea Grattissima, Olea Europaea (Olive) fruit oil, Tocopheryl Acetate (vit.E), Panthenol (vit. B5), Anthemis Nobilis (Chamomile) extract, Punica Granatum (Pomegranate) extract, Camelia Sinensis extract.

SPA PHARMA REGENERATING POMEGRANATE CREAM 
octinoxate, octocrylene, avobenzone, homosalate cream cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 69435-1603
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE5 g  in 100 mL
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE7.5 g  in 100 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE5 g  in 100 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE2 g  in 100 mL
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE3 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CETEARYL GLUCOSIDE (UNII: 09FUA47KNA)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
ISOHEXADECANE (UNII: 918X1OUF1E)  
GLYCERIN (UNII: PDC6A3C0OX)  
SIMMONDSIA CHINENSIS SEED (UNII: D24K2Q1F6H)  
SHEA BUTTER (UNII: K49155WL9Y)  
POTASSIUM CETYL PHOSPHATE (UNII: 03KCY6P7UT)  
NIACINAMIDE (UNII: 25X51I8RD4)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
SEA SALT (UNII: 87GE52P74G)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
PANTHENOL (UNII: WV9CM0O67Z)  
CHAMOMILE FLOWER OIL (UNII: 60F80Z61A9)  
POMEGRANATE SEED OIL (UNII: 0UI45XV0T6)  
CAMELINA SATIVA WHOLE (UNII: W42JFE4HON)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 69435-1603-150 mL in 1 CONTAINER; Type 0: Not a Combination Product03/23/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35202/09/201608/14/2019
Labeler - Peer Pharma Ltd. (514678390)
Establishment
NameAddressID/FEIBusiness Operations
Peer Pharma Ltd.514678390manufacture(69435-1603)

Revised: 8/2019
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.